Gastrointestinal and Liver Diseases Research Center, Guilan University of Medical Sciences, Rasht, Iran.
Student Research Committee, School of Medicine, Guilan University of Medical Sciences, Rasht, Iran.
Sci Rep. 2023 Oct 14;13(1):17457. doi: 10.1038/s41598-023-44487-8.
The current meta-analysis aims to investigate the existing articles that evaluated the implications of a positive family history of cancer on the risk of colorectal cancer (CRC) within the EMRO countries. We employed PubMed, Scopus, and Web of Science as search databases for this study. To assess the quality of the selected articles, we utilized the Newcastle-Ottawa (NCO) checklist. In comparing the impact of a family history of cancer between the case and control groups, we computed the odds ratio (OR) along with its corresponding 95% confidence interval (CI). Finally, 27 articles were selected for meta-analysis. The result of the meta-analysis showed a significant association between the presence of a family history of CRC or any cancers and CRC (OR 2.21; 95% CI 1.54-3.17; P < 0.001, OR 1.76; 95% CI 1.27-2.42; P = 0.001, respectively). Our findings underscore the critical importance of timely screening and early identification for individuals with a family history of cancer. By fostering close coordination among healthcare facilities and actively promoting the adoption of screening methods for early detection, we have the potential to significantly reduce both mortality rates and financial burdens of CRC on the general public, ultimately leading to enhanced patient outcomes.
本荟萃分析旨在调查评估 EMRO 国家中癌症家族史对结直肠癌(CRC)风险影响的现有文献。我们使用 PubMed、Scopus 和 Web of Science 作为本研究的搜索数据库。为了评估所选文章的质量,我们使用了纽卡斯尔-渥太华(NCO)清单。在比较病例组和对照组癌症家族史的影响时,我们计算了比值比(OR)及其相应的 95%置信区间(CI)。最后,选择了 27 篇文章进行荟萃分析。荟萃分析的结果表明,CRC 或任何癌症家族史与 CRC 之间存在显著关联(OR 2.21;95%CI 1.54-3.17;P<0.001,OR 1.76;95%CI 1.27-2.42;P=0.001)。我们的研究结果强调了对有癌症家族史的个体进行及时筛查和早期识别的重要性。通过加强医疗机构之间的密切协调,并积极推广用于早期检测的筛查方法,我们有潜力显著降低 CRC 的总体死亡率和公众的经济负担,最终改善患者的预后。